tiprankstipranks
Advertisement
Advertisement
Ideaya Biosciences announces $300M common stock offering
PremiumThe FlyIdeaya Biosciences announces $300M common stock offering
7d ago
Analyst Reiterates Buy on IDEAYA, Citing Strong Oncology Pipeline and Partnerships with Unchanged $62 Price Target
Premium
Ratings
Analyst Reiterates Buy on IDEAYA, Citing Strong Oncology Pipeline and Partnerships with Unchanged $62 Price Target
12d ago
IDEAYA, Roche launch PRMT5 and pan-RAS collaboration
Premium
Company Announcements
IDEAYA, Roche launch PRMT5 and pan-RAS collaboration
13d ago
Ideaya’s IDE574 Trial Signals New Optionality in Advanced Solid Tumors and Breast Cancer
PremiumCompany AnnouncementsIdeaya’s IDE574 Trial Signals New Optionality in Advanced Solid Tumors and Breast Cancer
26d ago
Ideaya Biosciences price target lowered to $50 from $52 at Mizuho
Premium
The Fly
Ideaya Biosciences price target lowered to $50 from $52 at Mizuho
1M ago
IDEAYA Biosciences Files New Shelf Registration Statement
Premium
Company Announcements
IDEAYA Biosciences Files New Shelf Registration Statement
1M ago
Ideaya Biosciences price target raised to $53 from $49 at RBC Capital
PremiumThe FlyIdeaya Biosciences price target raised to $53 from $49 at RBC Capital
2M ago
Ideaya Biosciences price target raised to $65 from $60 at Truist
Premium
The Fly
Ideaya Biosciences price target raised to $65 from $60 at Truist
2M ago
Ideaya Biosciences rises 22.8%
Premium
The Fly
Ideaya Biosciences rises 22.8%
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100